年轻与老年ST段抬高型心肌梗死患者的流行病学、治疗与结局比较
该研究基于新加坡心肌梗死登记数据库,分析2007年1月至2014年12月间14006例STEMI病例,其中33.9%为老年(≥65岁)患者。老年患者门球时间中位数更长(73 vs 64分钟,P<0.001),接受PCI的比例更低(比例差=-23.6%,95%CI -25.3至-22.0)。未接受PCI时,老年患者30天死亡风险(HR 1.65,95%CI 1.36至1.99,P<0.001)和1年死亡风险(HR 1.83,95%CI 1.57至2.14,P<0.001)均升高。PCI的1年生存获益在65岁后开始下降,85岁后下降最明显,作者认为需谨慎权衡PCI风险与获益,尤其对高龄患者。
要点
- 老年(≥65岁)STEMI患者接受PCI的比例较年轻患者低23.6%(95%CI -25.3至-22.0)。
- 老年STEMI患者门球时间中位数73分钟,年轻患者64分钟(P<0.001)。
- 未接受PCI时,老年患者30天死亡HR 1.65(95%CI 1.36至1.99),1年死亡HR 1.83(95%CI 1.57至2.14)。
- PCI的1年生存获益在65岁后开始下降,85岁后下降最明显。
- 作者认为需谨慎权衡PCI风险与获益,尤其对高龄患者。
适用人群与场景
- 新加坡心肌梗死登记数据库中2007年1月至2014年12月收录的STEMI患者。
- 按年龄分为年轻组(<65岁)和老年组(≥65岁)。
研究设计与关键结果
- 研究类型为基于新加坡心肌梗死登记数据库的分析,共纳入14006例STEMI病例,其中33.9%为老年(≥65岁)患者。
- 老年患者门球时间中位数73分钟 vs 年轻患者64分钟(P<0.001)。
- 老年患者接受PCI的比例较年轻患者低,比例差=-23.6%(95%CI -25.3至-22.0)。
- 未接受PCI时,老年患者30天死亡HR 1.65(95%CI 1.36至1.99,P<0.001),年轻患者HR 1.10(95%CI 0.79至1.54,P=0.573)。
- 未接受PCI时,老年患者1年死亡HR 1.83(95%CI 1.57至2.14,P<0.001),年轻患者HR 1.41(95%CI 1.09至1.83,P=0.009)。
- PCI的1年生存获益在65岁后开始下降,85岁后下降最明显。
证据类型、等级与局限
- 证据类型:基于登记数据库的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需谨慎权衡PCI的风险与获益,尤其对高龄患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: With an ageing population, there is a need to understand the relative risk/benefit of interventions for elderly ST segment elevation myocardial infarction (STEMI) patients. The primary aim of this study was to compare epidemiology, treatments and outcomes between young and elderly STEMI patients. Our secondary aim was to determine the cut-off age when the benefits of primary percutaneous coronary intervention (PCI) were less pronounced.
METHODS: Data were collected by the Singapore Myocardial Infarction Registry. Patients were categorised into young (age <65 years) and elderly STEMI (age ≥65 years) patients.
RESULTS: We analysed 14 006 STEMI cases collected between January 2007 and December 2014; 33.9% were elderly STEMI patients. Elderly STEMI patients had longer median door to balloon (73 vs 64 min, P<0.001) time and were less likely to receive PCI (proportion difference=-23.6%, 95% CI -25.3 to -22.0). In the absence of PCI, elderly STEMI patients had a higher mortality within 30 days (elderly: HR 1.65, 95% CI 1.36 to 1.99, P<0.001; young: HR 1.10, 95% CI 0.79 to 1.54, P=0.573) and 1 year (elderly: HR 1.83, 95% CI 1.57 to 2.14, P<0.001; young: HR 1.41, 95% CI 1.09 to 1.83, P=0.009) of admission. The 1 year survival benefit of PCI started to decline after the age of 65 years.
CONCLUSION: Elderly STEMI patients were less likely to receive PCI and had longer door to balloon times. Survival benefit of PCI decreased after the age of 65 years, with the decline most evident from age 85 years onwards. The risks of PCI need to be weighed carefully against its benefits, especially in very elderly patients.
参考来源
- Pek PP, Zheng H, Ho AFW, et al. Comparison of epidemiology, treatments and outcomes of ST segment elevation myocardial infarction between young and elderly patients. Emerg Med J. 2018. PMID: 29545356. doi:10.1136/emermed-2017-206754
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。